Skip to main content
Clinical Trials/CTRI/2024/12/077520
CTRI/2024/12/077520Not yet recruitingNot Applicable

Comparison of Effectiveness of Fractional CO2 Laser against Intralesional Triamcinolone Acetonide in the treatment of Keloids

Dr Deepak Mudgal1 site in 1 country50 target enrollmentStarted: December 2, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
Comparison of improvement of height with fractional co2 laser against intralesional triamcinolone acetonide in the treatment of keloids

Study Overview

Brief Summary

The study â€œCOMPARISON OF EFFECTIVENESS OF FRACTIONAL CO2 LASER AGAINSTINTRALESIONAL TRIAMCINOLONE ACETONIDEIN THE TREATMENT OF KELOIDS” will be conducted in the Department of Dermatology, Venerology & Leprosy, Varun Arjun Medical College and Rohilkhand Hospital, Banthra, Shahjahanpur, Uttar Pradesh 242307 The study will be conducted on subjects with Keloid attending the outpatient clinic in the Department of Dermatology, Venerology & Leprosy, Varun Arjun Medical College and Rohilkhand Hospital, Banthra, Shahjahanpur, Uttar Pradesh based on inclusion and exclusion criteria. All patients selected for the study will undergo detailed history taking and written informed consent. Patients will be allocated randomly into 2 groups Group A will receive fractional CO2 laser therapy Group B will receive intralesional triamcinolone acetonide injections

Study Design

Study Type
Interventional
Allocation
Other
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients diagnosed with keloids.
  • Patients aged 18 years and above.
  • Patients having keloids of size 1cm to 20cm in greatest dimension.
  • Patients willing to undergo either fractional CO2 laser therapy or intralesional triamcinolone acetonide injections.
  • Patients willing to participate in the study.

Exclusion Criteria

  • Subjects with a past of allergic reaction or contraindications to triamcinolone acetonide injections.
  • Individuals with active skin infections or other dermatological conditions that may interfere with keloid treatment.
  • Patients who have undergone treatment for keloid within the past 6 months.
  • Pregnant or breastfeeding individuals.

Outcomes

Primary Outcomes

Comparison of improvement of height with fractional co2 laser against intralesional triamcinolone acetonide in the treatment of keloids

Time Frame: Once every month for six month | Once every three month for six month

Secondary Outcomes

  • Comparison of improvement of texture with fractional co2 laser against intralesional triamcinolone acetonide in the treatment of keloids(Once every month for six month)

Investigators

Sponsor
Dr Deepak Mudgal
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Deepak Mudgal

Varun Arjun Medical College and Rohilkhand Hospital

Study Sites (1)

Loading locations...

Similar Trials